Bloodstream Infections Laboratory Practice Survey

Improving the Impact of Laboratory Practice Guidelines: A New Paradigm for Metrics- American Society for Microbiology

Appendix M3 BSI Survey 06232015

BSI - Baseline

OMB: 0920-1096

Document [pdf]
Download: pdf | pdf
Appendix M3
Bloodstream Infections Laboratory Practice Survey
INTRODUCTION
Form Approved
OMB No. 0920-XXXX
Exp. Date xx/xx/20xx
Purpose of the Survey: This survey is being performed for the Centers for Disease Control and Prevention
(CDC) and the American Society for Microbiology (ASM) to learn about laboratories' current practices related
to the effectiveness of rapid diagnostic tests to promote more accurate and timely administration of targeted
antibiotic therapy for patients with bloodstream infections with the goal of improving practice and patient care.
This survey will take approximately 20 minutes to complete.
Security Information: All information collected in this survey will be kept in a secure manner. We ask you to
include your CLIA number to ensure that only one response per laboratory is recorded. We also ask you to
include your email address to follow-up if needed. Your CLIA number and email address will not be stored in
a database and they will not be linked to your survey responses. Your IP address will NOT be retained.
Participation is voluntary; you are free to withdraw from this survey at any time. If at any point you do not want
to continue, you can simply leave this website. If you do not click on the “done" button at the end of the
survey, your answers and participation will not be recorded.
Asterisks (*): Questions marked with an asterisk require an answer before you can proceed to the next
question.
How the findings will be used: The results from the survey will be compiled and shared in aggregate as a
learning tool, presented at professional conferences, and potentially published in a professional journal in the
field of laboratory science.
Contact Information: If you have concerns or questions about this survey please address them
to [email protected].
Agreement: By beginning the survey, you acknowledge that you have read this information and agree to
participate in this survey, with the knowledge that you are free to withdraw your participation at any time
without penalty.
Public reporting burden of this collection of information is estimated to average 20 minutes per response,
including the time for reviewing instructions, searching existing data sources, gathering and maintaining the
data needed, and completing and reviewing the collection of information. An agency may not conduct or
sponsor, and a person is not required to respond to a collection of information unless it displays a currently
valid OMB control number. Send comments regarding this burden estimate or any other aspect of this
collection of information, including suggestions for reducing this burden to CDC/ATSDR Information
Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920XXXX).

Thank you for taking the time to complete this CDC and ASM survey. Your feedback is important for guiding
CDC and ASM in their efforts to improve laboratory practice and patient care. The survey should take
approximately 20 minutes of your time. All answers will remain completely anonymous.

* 1. Position/Title of Person Completing Survey:

* 2. Email address:

* 3. Laboratory Name:

* 4. CLIA #:

* 5. How did you learn about this survey?
Laboratory Response Network Request
ClinMicroNet
DivCNet
Clinical Microbiology Issues Update
Microbe, ASM's monthly new magazine
Other (please specify)

* 6. Did you already fill out this survey?
Yes

If answered "Yes", respondents have completed the survey.

No

7. Date:
MM
12/05/2015

DD

/

YYYY

/

Bloodstream Infections Laboratory Practice Survey
DEMOGRAPHICS

* 8. Which of the following best describes your laboratory setting? (Select the best choice.)
University hospital/Academic medical center
City/County/State Hospital
Military/VA Hospital
Other type of hospital that is not listed above
Independent laboratory
Public Health Department,non-hospital
Physician office/ambulatory care laboratory
Other (please specify)

* 9. How would you characterize your institution?
For profit
Non-profit

* 10. How many pathologists or other physicians are in your laboratory? (Do not include residents,
fellows or trainees/medical students.)

* 11. Is your laboratory located in an institution that provides direct patient care?
Yes
No

Bloodstream Infections Laboratory Practice Survey
DEMOGRAPHICS
* 12. My institution is
hospital based.
non-hospital based.

* 13. What kind of patient population is at your institution? (Select all that apply.)
Inpatient
Outpatient
Non-patient
Other (please specify)

Bloodstream Infections Laboratory Practice Survey
DEMOGRAPHICS
* 14. How many hospital beds does the microbiology section serve?
>500 beds
101-500 beds
50-100 beds
<50 beds
Only have outpatients

* 15. What is your laboratory's zip code?

* 16. Are any of your laboratory staff currently members of the American Society for Microbiology
(ASM)?
Yes

If answered "No" or "Do not know",

No

respondents skip to question 18.

Do not know

Bloodstream Infections Laboratory Practice Survey
DEMOGRAPHICS

* 17. Do any of those members subscribe to (select all that apply)--

ASM's ClinMicroNet listserv
ASM's DivCNet listserv
No, do not subscribe
Do not know

* 18. Does the microbiology laboratory have a doctoral-level clinical scientist or consultant?
Yes
No

If answered "No", respondents skip to question 20.

Bloodstream Infections Laboratory Practice Survey
DEMOGRAPHICS
* 19. What is their board certification? (Select all that apply.)
D(ABMM) Diplomate, American Board of Medical Microbiology
D(ABB) Diplomate, American Board of Bioanalysis, HCLD (High Complexity Laboratory Director)
D(ABB) Diplomate, American Board of Bioanalysis, BCLD (Bioanalyst Clinical Laboratory Director)
Ph.D., other board certified
Ph.D., non-board certified
ABP (American Board of Pathology) Sub-boarded in Medical Microbiology
ABIM (American Board of Internal Medicine) Sub-boarded in Infectious Disease
M.D./D.O.
Do not know
Other (please specify)

Bloodstream Infections Laboratory Practice Survey
CURRENT PRACTICE
* 20. Does your hospital have an antibiotic stewardship program?
Yes
No
Do not know

Bloodstream Infections Laboratory Practice Survey
CURRENT PRACTICE
* 21. In your institution, which of the following categories of people can change therapy? (Check all
that apply.)
Medical staff physicians (physician with institutional privileges)
House staff physicians (residents, trainees, fellows)
Infectious disease physicians
Hospitalists
Pharmacists
Other (please specify)

* 22. Do you currently use a rapid method to quickly identify blood culture isolates?
Yes
No

Bloodstream Infections Laboratory Practice Survey
CURRENT PRACTICE
* 23. Do you use rapid Gram stains on positive blood cultures (for purposes of this survey, rapid is
defined as one hour or less turn-around-time)?
Yes
No

* 24. Is Gram stain performed before a molecular test?
Yes
No
Not applicable

* 25. Do you use phenotypic tests (e.g. performed on positive bottle or pellet [e.g. coagulase, latex
assay])?
Yes
No

If answered "No", respondents skip to question 27.

Bloodstream Infections Laboratory Practice Survey
CURRENT PRACTICE
* 26. Which phenotypic tests do you use?

* 27. Which of the following FDA cleared molecular tests do you use? (Select all that apply.)
PNA FISH
Verigene
FilmArray
Cepheid MRSA/SA BC
Not applicable
Other (please specify)

* 28. Do you use non-FDA cleared molecular tests?
Yes

If answered "No", respondents skip to question 30.

No

Bloodstream Infections Laboratory Practice Survey
CURRENT PRACTICE
* 29. Which organisms do you test for with non-FDA cleared molecular tests?

* 30. What is your approximate turn-around-time for reporting rapid results on molecular tests?

* 31. If you are using PNA FISH, what organism(s) are you testing for? (Enter not applicable if you are
not using this test.)

* 32. If you are using Verigene, what organism(s) are you testing for? (Enter not applicable if you are
not using this test.)

* 33. If you are using FilmArray, what organism(s) are you testing for? (Enter not applicable if you are
not using this test.)

* 34. If you are using other molecular tests, what organism(s) are you testing for? (Enter not
applicable if you are not using this test.)


File Typeapplication/pdf
File TitleView Survey
File Modified2015-07-24
File Created2015-06-18

© 2024 OMB.report | Privacy Policy